⌘K

Login Start Free

Home/Filings/4/0001144204-16-110084

4//SEC Filing

CASI Pharmaceuticals, Inc. 4

Accession 0001144204-16-110084

CIK 0000895051operating

View on SEC.gov Company Profile

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 7:00 PM ET

Size

5.2 KB

Accession

0001144204-16-110084

Insider Transaction Report

Form 4

Period: 2016-06-24

CASI Pharmaceuticals, Inc.CASI

Chief Executive Officer

Transactions

Award
Stock Options(Right to Buy)
2016-06-24+86,486→ 86,486 total
Exercise: $1.15From: 2016-06-24Exp: 2026-06-24→ Common Stock (86,486 underlying)

Documents

1 file

4
v443082_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000895051

Filing Metadata

Form type: 4
Filed: Jun 26, 8:00 PM ET
Accepted: Jun 27, 7:00 PM ET
Size: 5.2 KB

View on SEC.gov